David M. Hume Memorial Award

Wolfgang Winkelmayer, MD, MPH, ScD


Professor and Gordon A. Cain Chair in Nephrology, Baylor College of Medicine


The David M. Hume Memorial Award was created in memory of one of the National Kidney Foundation's most distinguished members. The Hume Award is the highest honor given to a distinguished scientist-clinician in the field of kidney and urologic diseases. It is bestowed upon an individual who exemplifies the high ideals of scholarship and humanitarianism in an outstanding manner.

Wolfgang C. Winkelmayer is the Gordon A. Cain Chair in Nephrology, a Professor of Medicine, and the Chief of the Section of Nephrology at Baylor College of Medicine in Houston, Texas. Originally from Vienna, Austria, where he attended medical school and received his internal medicine and nephrology training, Dr. Winkelmayer earned Master of Public Health degree (Health Care Management) and Doctor of Science (Health Policy) degrees from Harvard. As junior faculty at Brigham and Women¹s Hospital/Harvard Medical School and, later, as Director of Clinical Research in the Division of Nephrology at Stanford University School of Medicine, he established himself as a leader in the emerging discipline of comparative effectiveness research. Dr. Winkelmayer's main areas of research interest include treatments of chronic kidney disease-associated anemia as well as the effectiveness and safety of interventions for cardiovascular disease in patients with kidney disease. He has an excellent track record of garnering federal and foundation funding for this research, which uses real-world data, to which he applies sophisticated, cutting-edge study designs and methodologies. He has served on several steering committees and data safety monitoring boards of trials in kidney disease. He has published >500 manuscripts, including in the leading general medical and nephrology, cardiovascular, and transplant subspecialty journals. 

Dr. Winkelmayer has a profound interest in medical publishing. He has served as an Associate Editor for JAMA for 15 years and he is the incoming Editor-in-Chief of the American Journal for Kidney Diseases. He chaired the leading guideline organization in nephrology, Kidney Disease: Improving Global Outcomes (KDIGO), from 2016 to 2023. He is an elected member of the American Society for Clinical Investigation and the American Clinical and Climatological Association.